A benefit-risk assessment of daridorexant for the treatment of insomnia using patient preference data from two phase 3 trials
| العنوان: | A benefit-risk assessment of daridorexant for the treatment of insomnia using patient preference data from two phase 3 trials |
|---|---|
| المؤلفون: | S. Heidenreich, A. Phillips-Beyer, M. Ross, G. Nie Chua, I. Fietze, D. Mayleben |
| المصدر: | Sleep Medicine. 100:S106-S107 |
| بيانات النشر: | Elsevier BV, 2022. |
| سنة النشر: | 2022 |
| مصطلحات موضوعية: | General Medicine |
| تدمد: | 1389-9457 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::b2995aa2fb281cf0191db072bb3bf5f2 https://doi.org/10.1016/j.sleep.2022.05.296 |
| حقوق: | CLOSED |
| رقم الأكسشن: | edsair.doi...........b2995aa2fb281cf0191db072bb3bf5f2 |
| قاعدة البيانات: | OpenAIRE |
Full Text via ClinicalKey | تدمد: | 13899457 |
|---|